cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18–59 years, with no restriction on sex; 2. Pathologically confirmed advanced malignancy (TNM stage IV or deemed unsuitable for curative treatment based on clinical assessment); 3. Estimated life expectancy of >=3 months; 4. Karnofsky Performance Status (KPS) score >=50; 5. Normal cognitive function, with the ability to clearly understand the study content and express personal preferences (confirmed by MMSE screening); 6. Having at least one primary family caregiver (spouse, adult child, or other primary relative) who is able to participate in ACP discussions; 7. Family members willing to jointly participate in the intervention process; 8. Voluntary participation with provision of written informed consent; 9. Agreement to random assignment and subsequent follow-up.
Exclusion criteria
Exclusion criteria: 1. Presence of severe psychiatric disorders (e.g., schizophrenia, bipolar disorder) or significant cognitive impairment; 2. Presence of severe organ failure (e.g., New York Heart Association class IV heart failure, end-stage renal disease) that may impede effective communication and participation; 3. Rapid disease progression with an expected survival of <3 months; 4. Inability to comply with study follow-up (e.g., planned short-term treatment outside the study site or relocation); 5. Prior receipt of formal advance care planning (ACP) interventions or participation in similar studies; 6. Refusal of random assignment or withdrawal of informed consent during the study period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient–Family Decision Conflict; | — |
Secondary
| Measure | Time frame |
|---|---|
| Advance Care Planning (ACP) wishes fulfillment rate;Sense of dignity;Level of psychological distress;Care satisfaction;Quality of life; Quality of Communication; | — |
Countries
China
Contacts
Tianjin Medical University Cancer Institute & Hospital